p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment
- PMID: 19170070
- DOI: 10.1002/jcp.21705
p53-mediated regulation of cell cycle progression: pronounced impact of cellular microenvironment
Abstract
Data on the biological effects of some overexpressed oncogenes and their cooperation with cellular factors are, at least partially, contradictory. There are reports on the strong pro-apoptotic action of temperature-sensitive (ts) p53(135val) in transformed cells at permissive temperature. However, in our experience very high levels of p53(135val) induce in transformed rat cells at permissive temperature cell cycle arrest but not apoptosis. Comparison of the experimental protocols reveals that cells used for transfection strongly differ. Therefore, we decided to explore the impact of primary cells used for generation of cell clones on the biological effects evoked by p53 and c-Ha-Ras. In the present study, we used primary rat cells (RECs) isolated from rat embryos of different age: at 13.5 gd (y) and 15.5 gd (o). We immortalized rat cells using ts p53(135val) mutant and additionally generated transformed cells after co-transfection with oncogenic Ras. The RECs were transfected with a constitutively activated Ha-Ras protein, a mutation that is found in a wide variety of human tumors. The ts p53(135Val) mutant, switching between wild-type (wt) and mutant conformation, offers the possibility to study the escape from p53-mediated cell cycle control in a model of malignant transformation in cells with the same genetic background. Surprisingly, the kinetics of cell proliferation at non-permissive temperature and that of cell cycle arrest at 32 degrees C strongly differed between cell clones established from yRECs and oRECs, thereby indicating that overexpression of genes such as ts p53(135Val) mutant and oncogenic-Ha-Ras does not fully override the intrinsic cellular program.
Similar articles
-
Oncogenes do not Fully Override Cell-intrinsic Traits: Pronounced Impact of the Cellular Programme.Cancer Microenviron. 2009 Sep 4;2(Suppl 1):215-25. doi: 10.1007/s12307-009-0024-9. eCollection 2009 Sep. Cancer Microenviron. 2009. PMID: 19731086 Free PMC article.
-
The p53 tumor suppressor gene and gene product.Princess Takamatsu Symp. 1989;20:221-30. Princess Takamatsu Symp. 1989. PMID: 2488233 Review.
-
Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.Cell Growth Differ. 1990 Dec;1(12):571-80. Cell Growth Differ. 1990. PMID: 2288874
-
Prevention of farnesylation of c-Ha-Ras protein enhances synergistically the cytotoxic action of doxorubicin in cycling but not in quiescent cells.J Cell Biochem. 2006 Dec 15;99(6):1664-76. doi: 10.1002/jcb.21028. J Cell Biochem. 2006. PMID: 16823773
-
Biochemical, immunological, and functional aspects of the growth-suppressor/oncoprotein p53.Crit Rev Oncog. 1992;3(3):233-56. Crit Rev Oncog. 1992. PMID: 1616956 Review.
Cited by
-
Oncogenes do not Fully Override Cell-intrinsic Traits: Pronounced Impact of the Cellular Programme.Cancer Microenviron. 2009 Sep 4;2(Suppl 1):215-25. doi: 10.1007/s12307-009-0024-9. eCollection 2009 Sep. Cancer Microenviron. 2009. PMID: 19731086 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous